These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1267 related articles for article (PubMed ID: 34798898)

  • 1. Remodeling of the tumor microenvironment via disrupting Blimp1
    Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
    Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
    Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
    J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic depletion of CCR8
    Van Damme H; Dombrecht B; Kiss M; Roose H; Allen E; Van Overmeire E; Kancheva D; Martens L; Murgaski A; Bardet PMR; Blancke G; Jans M; Bolli E; Martins MS; Elkrim Y; Dooley J; Boon L; Schwarze JK; Tacke F; Movahedi K; Vandamme N; Neyns B; Ocak S; Scheyltjens I; Vereecke L; Nana FA; Merchiers P; Laoui D; Van Ginderachter JA
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.
    Kumagai S; Koyama S; Itahashi K; Tanegashima T; Lin YT; Togashi Y; Kamada T; Irie T; Okumura G; Kono H; Ito D; Fujii R; Watanabe S; Sai A; Fukuoka S; Sugiyama E; Watanabe G; Owari T; Nishinakamura H; Sugiyama D; Maeda Y; Kawazoe A; Yukami H; Chida K; Ohara Y; Yoshida T; Shinno Y; Takeyasu Y; Shirasawa M; Nakama K; Aokage K; Suzuki J; Ishii G; Kuwata T; Sakamoto N; Kawazu M; Ueno T; Mori T; Yamazaki N; Tsuboi M; Yatabe Y; Kinoshita T; Doi T; Shitara K; Mano H; Nishikawa H
    Cancer Cell; 2022 Feb; 40(2):201-218.e9. PubMed ID: 35090594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl6 and Blimp1 reciprocally regulate ST2
    Koh B; Ulrich BJ; Nelson AS; Panangipalli G; Kharwadkar R; Wu W; Xie MM; Fu Y; Turner MJ; Paczesny S; Janga SC; Dent AL; Kaplan MH
    J Allergy Clin Immunol; 2020 Nov; 146(5):1121-1136.e9. PubMed ID: 32179158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.
    Kumagai S; Togashi Y; Kamada T; Sugiyama E; Nishinakamura H; Takeuchi Y; Vitaly K; Itahashi K; Maeda Y; Matsui S; Shibahara T; Yamashita Y; Irie T; Tsuge A; Fukuoka S; Kawazoe A; Udagawa H; Kirita K; Aokage K; Ishii G; Kuwata T; Nakama K; Kawazu M; Ueno T; Yamazaki N; Goto K; Tsuboi M; Mano H; Doi T; Shitara K; Nishikawa H
    Nat Immunol; 2020 Nov; 21(11):1346-1358. PubMed ID: 32868929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.
    Yoshida K; Okamoto M; Sasaki J; Kuroda C; Ishida H; Ueda K; Ideta H; Kamanaka T; Sobajima A; Takizawa T; Tanaka M; Aoki K; Uemura T; Kato H; Haniu H; Saito N
    BMC Cancer; 2020 Jan; 20(1):25. PubMed ID: 31914969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated follicular regulatory T cells and antibody responses exacerbate experimental autoimmune encephalomyelitis.
    Luo L; Hu X; Dixon ML; Pope BJ; Leavenworth JD; Raman C; Meador WR; Leavenworth JW
    J Neuroinflammation; 2021 Jan; 18(1):27. PubMed ID: 33468194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis.
    Li Y; Wang Z; Lin H; Wang L; Chen X; Liu Q; Zuo Q; Hu J; Wang H; Guo J; Xie L; Tang J; Li Z; Hu L; Xu L; Zhou X; Ye L; Huang Q; Xu L
    Front Immunol; 2020; 11():806. PubMed ID: 32477338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor.
    Shen E; Rabe H; Luo L; Wang L; Wang Q; Yin J; Yang X; Liu W; Sido JM; Nakagawa H; Ao L; Kim HJ; Cantor H; Leavenworth JW
    Cell Rep; 2019 Nov; 29(7):1848-1861.e6. PubMed ID: 31722202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy.
    Eschweiler S; Clarke J; Ramírez-Suástegui C; Panwar B; Madrigal A; Chee SJ; Karydis I; Woo E; Alzetani A; Elsheikh S; Hanley CJ; Thomas GJ; Friedmann PS; Sanchez-Elsner T; Ay F; Ottensmeier CH; Vijayanand P
    Nat Immunol; 2021 Aug; 22(8):1052-1063. PubMed ID: 34168370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional repressor Blimp1 regulates follicular regulatory T-cell homeostasis and function.
    Yang G; Yang X; Zhang J; Li G; Zheng D; Peng A; Hu J; Xu L; Yang B; Yang H; Zhou W; Tuzun E; Li J
    Immunology; 2018 Jan; 153(1):105-117. PubMed ID: 28833081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma.
    Huang L; Xu Y; Fang J; Liu W; Chen J; Liu Z; Xu Q
    Front Immunol; 2021; 12():654749. PubMed ID: 33936081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
    Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
    Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.
    Redin E; Garmendia I; Lozano T; Serrano D; Senent Y; Redrado M; Villalba M; De Andrea CE; Exposito F; Ajona D; Ortiz-Espinosa S; Remirez A; Bertolo C; Sainz C; Garcia-Pedrero J; Pio R; Lasarte J; Agorreta J; Montuenga LM; Calvo A
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33658304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
    Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
    J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of Effector and Regulatory T cell function by Blimp1.
    Bankoti R; Ogawa C; Nguyen T; Emadi L; Couse M; Salehi S; Fan X; Dhall D; Wang Y; Brown J; Funari V; Tang J; Martins GA
    Sci Rep; 2017 Sep; 7(1):12078. PubMed ID: 28935958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin analog GO-Y030 boosts the efficacy of anti-PD-1 cancer immunotherapy.
    MaruYama T; Kobayashi S; Shibata H; Chen W; Owada Y
    Cancer Sci; 2021 Dec; 112(12):4844-4852. PubMed ID: 34529884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy.
    Schoonderwoerd MJA; Koops MFM; Angela RA; Koolmoes B; Toitou M; Paauwe M; Barnhoorn MC; Liu Y; Sier CFM; Hardwick JCH; Nixon AB; Theuer CP; Fransen MF; Hawinkels LJAC
    Clin Cancer Res; 2020 Jul; 26(14):3831-3842. PubMed ID: 32332012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations.
    Kugel CH; Douglass SM; Webster MR; Kaur A; Liu Q; Yin X; Weiss SA; Darvishian F; Al-Rohil RN; Ndoye A; Behera R; Alicea GM; Ecker BL; Fane M; Allegrezza MJ; Svoronos N; Kumar V; Wang DY; Somasundaram R; Hu-Lieskovan S; Ozgun A; Herlyn M; Conejo-Garcia JR; Gabrilovich D; Stone EL; Nowicki TS; Sosman J; Rai R; Carlino MS; Long GV; Marais R; Ribas A; Eroglu Z; Davies MA; Schilling B; Schadendorf D; Xu W; Amaravadi RK; Menzies AM; McQuade JL; Johnson DB; Osman I; Weeraratna AT
    Clin Cancer Res; 2018 Nov; 24(21):5347-5356. PubMed ID: 29898988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 64.